Skip to main content
. 2021 Feb 22;206(7):1609–1617. doi: 10.4049/jimmunol.2000991

FIGURE 1.

FIGURE 1.

rhERAPs stimulation favors monocyte activation and differentiation in specific subsets. PBMCs isolated from 15 HCs were stimulated with 100 ng/ml of rhERAP1, rhERAP2, or rhERAP1+rhERAP2 for 24 h. The percentage of total CD14+ CD16+), classical (CD14++CD16), intermediate (CD14++CD16+), and nonclassical (CD14+CD16++) monocytes expressing the activation markers DRII and CCR7 was assessed by flow cytometry. Mean values and SEM are shown. *p < 0.05, **p < 0.01.